glp 1 fda ban Compounded Semaglutide & Tirzepatide 2025: Safe Use Guide FDA takes aim at telehealth

Gaining Weight on GLP-1

At Gnosis by Lesaffre, we see this as an opportunity: creating science-based solutions for healthy weight maintenance

Get clear answers on fluid changes, early side effects, and medical guidance

GLP-1 receptor agonists may be superior to aspirin for primary prevention of colorectal cancer, according to study results presented at ASCO Gastrointestinal Cancers Symposium.A retrospective analysis of more than 281,000 people showed those who used GLP-1s exhibited a 36% reduced risk for colorectal cancer compared with those who used aspirin

Johnson & Johnsons Darzalex remained a standout performer in oncology

Challenges with GLP-1 Therapy: Many users experience energy dips, muscle loss, and nutrient deficiencies while on GLP-1 therapies like semaglutide